Suchergebnisse - "Ostrominski, John W"

PubPharm (35)

1

Contemporary American and European Guidelines for Heart Failure Management : JACC: Heart Failure Guideline Comparison

enthalten in: JACC. Heart failure | 2024

von Ostrominski, J. | DeFilippis, E. | Bansal, K. | +4

2

Chapter 2 : Clinical and Mechanistic Potential of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Heart Failure with Preserved Ejection Fraction

enthalten in: The American journal of medicine | 2024

von Ostrominski, J. | Vaduganathan, M.

3

Aspirin and diabetes prevention among healthy older adults-practice-changing or hypothesis-generating?

enthalten in: The lancet. Diabetes & endocrinology | 2024

von Ostrominski, J. | Aroda, V.

4

Qualitative evaluation of artificial intelligence-generated weight management diet plans

enthalten in: Frontiers in nutrition | 2024

von Kim, D. | Park, J. | Sharma, K. | +6

5

Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

enthalten in: Current atherosclerosis reports | 2024

von Ostrominski, J. | Powell-Wiley, T.

6

Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

enthalten in: Current atherosclerosis reports | 2023

von Ostrominski, J. | Powell-Wiley, T.

7

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : The DELIVER Trial

enthalten in: Circulation | 2023

von Ostrominski, J. | Vaduganathan, M. | Selvaraj, S. | +15

8

Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure : STEPping Across the Ejection Fraction Divide

enthalten in: Journal of the American College of Cardiology | 2023

von Vaduganathan, M. | Ostrominski, J.

CommentOn: J Am Coll Cardiol. 2023 Nov 28;82(22):2087-2096. - PMID 37993201

9

Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

enthalten in: JACC. Heart failure | 2023

von Ostrominski, J. | Thierer, J. | Claggett, B. | +15

CommentIn: JACC Heart Fail. 2023 Nov;11(11):1504-1506. - PMID 37565975

10

Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan : Insights From the PARAGON-HF Trial

enthalten in: Journal of cardiac failure | 2023

von Ostrominski, J. | Claggett, B. | Packer, M. | +9